Nubeqa (darolutamide)

pCPA File Number: 21244
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-metastatic Castration-resistant prostate cancer
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
PC0196-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: